This website uses cookies to enhance the user experience.
HL

Haakon Lude Sande1978

Shareholdings
3
16
Norway Business roles
10

Roles

Management

NameRoleTotal operating incomeTotal equityShares
Managing Director/CEO
28,925,398
1,000,000
33.3 %
indirectly
S
SANDE HOLDING AS
Managing Director/CEO
5,506,200
5,577,114
33.3 %
directly
N
NYE SANDE HOLDING AS
Managing Director/CEO
-
-
-

Boards

NameRoleTotal operating incomeTotal equityShares
Board Member
28,925,398
1,000,000
33.3 %
indirectly
S
SANDE HOLDING AS
Chairman
5,506,200
5,577,114
33.3 %
directly
U
ULRIKSDAL 1 AS
Board Member
8,571,252
997,510
33.3 %
indirectly
C
CRUISESPESIALISTEN AS
Board Member
53,690,894
1,626,352
33.3 %
indirectly
Z
ZERACRYL AS
Board Member
404,564
2,931,398
6.26 %
indirectly
D
DLS AS
Chairman
552,469
11,973,547
-
N
NYE SANDE HOLDING AS
Chairman
-
-
-
Last update: Oct 4, 2024

Related industries5

  • Accommodation and food service activities
  • Administrative and support service activities
  • Information and communication
  • Professional, scientific and technical activities
  • Real estate activities

Shares owned by Haakon Lude Sande

NameShare classTotal operating incomeTotal equityShare
S
SANDE HOLDING AS
B-aksjer
5,506,200
5,577,114
33.3 %
directly
28,925,398
1,000,000
33.3 %
indirectly
N
NAPRAPAT IVERSEN AS
0
-44,689
33.3 %
indirectly
U
ULRIKSDAL 1 AS
8,571,252
997,510
33.3 %
indirectly
C
CRUISESPESIALISTEN AS
53,690,894
1,626,352
33.3 %
indirectly
Z
ZERACRYL AS
404,564
2,931,398
6.26 %
indirectly
Z
ZNL ENERGY AS
0
10,150,926
0.85 %
indirectly
R
RECEIPTS HOLDING AS
0
4,296,069
0.7 %
indirectly
R
RECEIPTS AS
2,300,000
-6,165,029
0.7 %
indirectly
0
14,878
0.67 %
indirectly
B
BERGEN CARBON SOLUTIONS AS
31,000
246,935,000
0.67 %
indirectly
0
17,488
0.67 %
indirectly
B
BCS HØYANGER AS
0
-11,138
0.67 %
indirectly
0
17,492
0.67 %
indirectly
D
DIMEQ AS
982,323
9,301,437
0.65 %
indirectly
F
FRIENDR AS
0
9,396,834
0.6 %
indirectly
B
BUSINESSCLASS.COM AS
690,800
21,672,479
0.54 %
indirectly
N
NORDIC LIGHT NORWAY AS
Ordinære aksjer
69,440
-3,942,519
0.38 %
directly < 0.01 %
I
IMMUNOPHARMA AS
NO0010735335
14,110,340
195,301,042
0.03 %
directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024